STOCK TITAN

Simplify VettaFi Private Credit Stgy ETF Stock Price, News & Analysis

PCR NYSE

Company Description

The Simplify VettaFi Private Credit Strategy ETF (NYSE Arca: PCR) is an exchange-traded fund launched by Simplify Asset Management Inc. It is described as a private credit strategy ETF that seeks to give investors exposure to private credit markets while incorporating a dedicated credit hedge. PCR is part of Simplify’s alternatives and income-focused ETF lineup and is listed on the NYSE Arca exchange.

According to Simplify, PCR’s private credit strategy seeks to track the returns of the VettaFi Private Credit Index. This index is derived from a universe of Business Development Companies (BDCs) and publicly traded Closed-End Funds (CEFs) that are primarily engaged in private credit. Potential index constituents must meet stated minimum market capitalization and liquidity requirements and are evaluated using proprietary percentile scores based on volatility and dividend yield.

A key feature highlighted for PCR is its proprietary credit hedging strategy. The fund employs a hedge that goes long stocks with high-quality metrics and short stocks that exhibit low-quality metrics. Simplify notes that this hedge has historically shown a positive correlation with credit spreads and a historical positive carry. The goal of this structure is to pair private credit exposure with a managed approach to credit risk, particularly during adverse credit events or periods of credit spread widening.

As an actively managed ETF, PCR is subject to the risk that its strategy may not achieve the intended results. The fund may use derivative instruments, including swaps and options, and may invest in other ETFs. The disclosures emphasize that derivatives can involve risks different from, or greater than, investing directly in securities, including counterparty risk, valuation risk, and the possibility that changes in derivative values may not closely track the underlying asset, rate, or index.

The risk disclosures for PCR also reference exposure to high yield debt ("junk bonds"), credit risk, and liquidity risk. High yield securities and unrated securities of similar credit quality are described as speculative with respect to an issuer’s ability to make principal and interest payments and may be more volatile than higher-rated securities. The fund is identified as non-diversified, meaning it may invest a larger portion of its assets in fewer issuers than a diversified fund, which can increase fluctuations in its share price.

Fixed income-related risks are also highlighted, including the potential impact of rising interest rates on bond prices and fund value, as well as prepayment risk and credit risk. Swaps used in the strategy are noted as being subject to tracking risk if they do not perfectly substitute for the instruments they are intended to hedge or replace.

The disclosures characterize PCR as a recently organized management investment company with no operating history at the time of its introduction. As with other ETFs, investors are encouraged to review the fund’s prospectus or summary prospectus for detailed information on investment objectives, risks, charges, and expenses, and are reminded that an investment in the fund involves risk, including possible loss of principal.

In a later announcement, Simplify Asset Management reported that the previously disclosed net asset values (NAVs) per share of the Simplify VettaFi Private Credit Strategy ETF for a specified period were restated due to incorrect swaps financing rates. The notice provided a schedule of revised and original NAVs and indicated that the adjustments were effective as of a stated date. This event underscores the role of derivatives and financing assumptions in the fund’s valuation process.

Simplify Asset Management Inc. is described in the fund’s communications as a Registered Investment Adviser founded in 2020. The firm states that it focuses on helping advisors address portfolio challenges through options-based strategies that take into account real-world investor needs, market behavior, and the non-linear characteristics of options.

Stock Performance

$—
0.00%
0.00
Last updated:
-20.58%
Performance 1 year

SEC Filings

No SEC filings available for Simplify VettaFi Private Credit Stgy ETF.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in Simplify VettaFi Private Credit Stgy ETF (PCR) currently stands at 1.1 thousand shares, down 44.2% from the previous reporting period, representing 1.1% of the float. Over the past 12 months, short interest has increased by 145.4%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for Simplify VettaFi Private Credit Stgy ETF (PCR) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.7 days.

Frequently Asked Questions

What is the current stock price of Simplify VettaFi Private Credit Stgy ETF (PCR)?

The current stock price of Simplify VettaFi Private Credit Stgy ETF (PCR) is $19.97 as of March 6, 2026.

What is the Simplify VettaFi Private Credit Strategy ETF (PCR)?

The Simplify VettaFi Private Credit Strategy ETF (PCR) is an exchange-traded fund launched by Simplify Asset Management Inc. It is described as a private credit strategy ETF that seeks to provide investors with private credit exposure combined with a dedicated credit hedge.

On which exchange does PCR trade?

The Simplify VettaFi Private Credit Strategy ETF trades on the NYSE Arca exchange under the ticker symbol PCR.

What index does PCR’s private credit strategy seek to track?

PCR’s private credit strategy seeks to track the returns of the VettaFi Private Credit Index. This index is derived from a universe of Business Development Companies (BDCs) and publicly traded Closed-End Funds (CEFs) that are primarily engaged in private credit.

How are potential constituents for the VettaFi Private Credit Index selected?

Eligible potential constituents for the VettaFi Private Credit Index must meet minimum market capitalization and liquidity requirements. They are then assigned proprietary percentile rank scores based on volatility over the last 180 trading days and trailing twelve-month dividend yield.

What is the credit hedge used by PCR?

The fund employs a proprietary credit hedging strategy that goes long stocks with high-quality metrics and short stocks that exhibit low-quality metrics. Simplify notes that this hedge has historically had a positive correlation with credit spreads and a historical positive carry.

Is PCR actively managed?

Yes. The Simplify VettaFi Private Credit Strategy ETF is described as an actively managed fund and is subject to the risk that its strategy may not produce the intended results.

What are some key risks disclosed for investing in PCR?

Disclosures for PCR highlight risks including possible loss of principal, credit risk, high yield (junk bond) risk, derivatives risk, leverage risk, liquidity risk, and the risks associated with being a non-diversified fund. The fund’s use of derivatives such as swaps and options can introduce additional risks related to counterparty performance, valuation, and imperfect correlation with underlying assets.

How does PCR use derivatives in its strategy?

The fund may use derivative instruments, including options and swaps, as part of its strategy. The disclosures note that derivative prices can be highly volatile, may not correlate perfectly with underlying assets, and may involve counterparty and valuation risks. The fund’s use of leverage through derivatives can magnify gains or losses.

What was the NAV restatement mentioned for PCR?

Simplify Asset Management announced that previously disclosed net asset values (NAVs) per share of the Simplify VettaFi Private Credit Strategy ETF for certain dates were restated. The adjustments were attributed to incorrect swaps financing rates and a schedule of revised and original NAVs was provided in the announcement.

Who manages PCR?

PCR is launched and managed by Simplify Asset Management Inc., which is described as a Registered Investment Adviser founded in 2020 that focuses on options-based strategies designed to address portfolio challenges.